Notch Therapeutics
Ulrik Nielsen is a Director at Notch Therapeutics and Chief Executive Officer of Tidal Therapeutics. He is a co-founder and was President and CEO of Torque Therapeutics from 2015 until 2018. Prior to Torque, Ulrik co-founded and served as Chief Scientific Officer of Merrimack Pharmaceuticals (NASDAQ: MACK) until 2015. Ulrik trained at University of California, San Francisco and MIT and holds a PhD in molecular biology from the University of Copenhagen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Notch Therapeutics
Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.